English Spanish Chinese Russian German French Japanese Hindi Telugu Tamil

Anais de Pesquisa Clínica e Laboratorial

  • ISSN: 2386-5180
  • Índice h do diário: 17
  • Pontuação de citação de diário: 6.26
  • Fator de impacto do periódico: 5.31
Indexado em
  • Genamics JournalSeek
  • Infraestrutura Nacional de Conhecimento da China (CNKI)
  • CiteFactor
  • Diretório de Indexação de Periódicos de Pesquisa (DRJI)
  • publons
  • Euro Pub
  • Google Scholar
  • SHERPA ROMEU
  • Laboratórios secretos do mecanismo de pesquisa
Veja mais
Compartilhe esta página

Abstrato

The Global Modelling Consortium for Coronavirus and Cancer

Isabelle Moses*

The COVID-19 and Cancer Global Modeling Consortium (CCGMC) was established in May 2020 to address the global need for evidence regarding the impact of interruptions and their moderation. The CCGMC intends to organise pertinent research on COVID-19 and disease and set up illuminating demonstrating stages for malignant growth control decision-production. Three interconnected work streams have been established by the CCGMC to examine the impact of COVID-19 on the outcomes of malignant growth screening and analysis, and disease risk. The focus is on developing a framework that will allow for the distribution of regularly updated short- and long-term projections of malignant growth significant outcomes. A lot of attention is being paid to evaluating potential prioritisation and recovery strategies both during and after the serious social and wellbeing administration interruptions experienced globally.